Home › Funds › Koesten, Hirschmann & Crabtree, INC. › IBDX

Koesten, Hirschmann & Crabtree, INC. position in IBDX

ISHARES TR

Koesten, Hirschmann & Crabtree, INC. reported holding 15,645 shares of IBDX (ISHARES TR) in its Q3 2026 13F filing — a position valued at US$377K, representing 0.16% of its reported portfolio and ranking #33 among its reported holdings. Koesten, Hirschmann & Crabtree, INC. has disclosed IBDX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)15.64K sh
Reported value held$376.58K
Portfolio Weight0.16%
First reportedQ4 2023
Last changeAdd
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How Koesten, Hirschmann & Crabtree, INC.'s IBDX position evolved

Koesten, Hirschmann & Crabtree, INC. first disclosed a stake in IBDX in Q4 2023 at 5,100 shares (US$129K). The position peaked in Q2 2026 at 15,385 shares, worth US$388K. Across 12 filings, Koesten, Hirschmann & Crabtree, INC. increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 15,645 shares valued at US$377K — an increase of 260 shares quarter over quarter.. Notable position changes include a 81% increase in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 5.10K $128.67K New
Q1 2024 5.10K $126.53K Hold
Q2 2024 5.10K $126.53K Hold
Q3 2024 5.10K $131.12K Hold
Q4 2024 5.80K $142.56K Add
Q1 2025 6.74K $168.43K Add
Q2 2025 7.32K $184.96K Add
Q3 2025 8.49K $217.64K Add
Q4 2025 8.49K $216.88K Hold
Q1 2026 8.49K $214.67K Hold
Q2 2026 15.38K $387.55K Add
Q3 2026 15.64K $376.58K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBDX and 13F data

IBDX (ISHARES TR) is a company whose sector is not yet classified in our data. 38 other funds we track also report a position in IBDX — the largest reported positions include Aptus Capital Advisors, LLC (US$162.6M), Capital Investment Advisors, LLC (US$88.3M), CAPITAL ADVISORS INC/OK (US$71.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBDX

All IBDX fund holders →

FAQ

How long has Koesten, Hirschmann & Crabtree, INC. held IBDX?

Koesten, Hirschmann & Crabtree, INC. has disclosed IBDX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Koesten, Hirschmann & Crabtree, INC.'s current position in IBDX?

As of Q3 2026, Koesten, Hirschmann & Crabtree, INC. holds 15.64K shares of IBDX (ISHARES TR), valued at $376.58K, representing 0.16% of its reported portfolio and ranking #33.

Has Koesten, Hirschmann & Crabtree, INC. been buying or selling IBDX?

In the latest 13F filing (Q3 2026), Koesten, Hirschmann & Crabtree, INC. increased its position in IBDX. The position peaked in Q2 2026 at 15.38K shares.

Which other funds hold IBDX?

Other major institutional holders of IBDX include Aptus Capital Advisors, LLC, Capital Investment Advisors, LLC, CAPITAL ADVISORS INC/OK, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.